Last Updated: November 13, 2026

Details for New Drug Application (NDA): 217893

« Back to Dashboard

NDA 217893 describes SCOPOLAMINE, which is a drug marketed by Actavis Labs Ut Inc, Amneal, Mylan Technologies, Padagis Us, Rhodes Pharms, Riconpharma Llc, and Zydus Pharms, and is included in seven NDAs. It is available from eleven suppliers. Additional details are available on the SCOPOLAMINE profile page.

The generic ingredient in SCOPOLAMINE is scopolamine. There is one drug master file entry for this compound. Twelve suppliers are listed for this compound. Additional details are available on the scopolamine profile page.

Summary for 217893

Tradename:	SCOPOLAMINE
Applicant:	Zydus Pharms
Ingredient:	scopolamine
Patents:	0

Pharmacology for NDA: 217893

Mechanism of Action	Cholinergic Antagonists

Suppliers and Packaging for NDA: 217893

Tradename	Generic Name	Dosage	NDA	Application Type	Supplier	National Drug Code	Package Code	Package
SCOPOLAMINE	scopolamine	SYSTEM;TRANSDERMAL	217893	ANDA	A-S Medication Solutions	50090-8154	50090-8154-0	4 POUCH in 1 CARTON (50090-8154-0) / 1 d in 1 POUCH
SCOPOLAMINE	scopolamine	SYSTEM;TRANSDERMAL	217893	ANDA	Zydus Pharmaceuticals USA Inc.	70710-1846	70710-1846-2	10 POUCH in 1 CARTON (70710-1846-2) / 1 PATCH in 1 POUCH / 3 d in 1 PATCH

Profile for product number 001

Active Rx/OTC/Discontinued:	RX	Dosage:	SYSTEM;TRANSDERMAL			Strength	1MG/72HR
Approval Date:	Aug 29, 2024	TE:	AB	RLD:	No

Complete Access Available with Subscription

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. We do not provide individual investment advice. This service is not registered with any financial regulatory agency. The information we publish is educational only and based on our opinions plus our models. By using DrugPatentWatch you acknowledge that we do not provide personalized recommendations or advice. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.